Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Best Momentum Stocks to Buy for January 21st

In This Article:

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 21st:

CareDx, Inc CDNA: This diagnostic solutions company for transplant patients and caregivers has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.5% over the last 60 days.

CareDx, Inc. Price and Consensus

CareDx, Inc. Price and Consensus
CareDx, Inc. Price and Consensus

CareDx, Inc. price-consensus-chart | CareDx, Inc. Quote

CareDx’s shares gained 13.6% over the last six months compared with the S&P 500’s advance of 7.7%. The company possesses a Momentum Score  of A.

CareDx, Inc. Price

CareDx, Inc. Price
CareDx, Inc. Price

CareDx, Inc. price | CareDx, Inc. Quote

Anavex Life Sciences Corp. AVXL: This clinical stage biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.8% over the last 60 days.

Anavex Life Sciences Corp. Price and Consensus

Anavex Life Sciences Corp. Price and Consensus
Anavex Life Sciences Corp. Price and Consensus

Anavex Life Sciences Corp. price-consensus-chart | Anavex Life Sciences Corp. Quote

Anavex’s shares gained 63.3% over the last three months compared with the S&P 500’s advance of 2.4%. The company possesses a Momentum Score of A.

Anavex Life Sciences Corp. Price

Anavex Life Sciences Corp. Price
Anavex Life Sciences Corp. Price

Anavex Life Sciences Corp. price | Anavex Life Sciences Corp. Quote

Alnylam Pharmaceuticals, Inc. ALNY: This biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 20.4% over the last 60 days.

Alnylam Pharmaceuticals, Inc. Price and Consensus

Alnylam Pharmaceuticals, Inc. Price and Consensus
Alnylam Pharmaceuticals, Inc. Price and Consensus

Alnylam Pharmaceuticals, Inc. price-consensus-chart | Alnylam Pharmaceuticals, Inc. Quote

Alnylam’s shares gained 1.6% over the past month compared with the S&P 500’s advance of 0.4%. The company possesses a Momentum Score of A.

Alnylam Pharmaceuticals, Inc. Price

Alnylam Pharmaceuticals, Inc. Price
Alnylam Pharmaceuticals, Inc. Price

Alnylam Pharmaceuticals, Inc. price | Alnylam Pharmaceuticals, Inc. Quote

 

See the full list of top ranked stocks here

 

Learn more about the Momentum score and how it is calculated here.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Alnylam Pharmaceuticals, Inc. (ALNY) : Free Stock Analysis Report

Anavex Life Sciences Corp. (AVXL) : Free Stock Analysis Report

CareDx, Inc. (CDNA) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research


Waiting for permission
Allow microphone access to enable voice search

Try again.